89989-01-5

Basic information

• Product Name: 1-(4-chloro-2-Methoxyphenyl)piperazine
• Synonyms: 1-(4-chloro-2-Methoxyphenyl)piperazine
• CAS NO: 89989-01-5
• Molecular Formula: C₁₁H₁₅ClN₂O
• Molecular Weight: 226.7026
• Mol File: 89989-01-5.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(4-chloro-2-Methoxyphenyl)piperazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-chloro-2-Methoxyphenyl)piperazine(89989-01-5)
• EPA Substance Registry System: 1-(4-chloro-2-Methoxyphenyl)piperazine(89989-01-5)

Safety Data

• Hazardous Substances Data: 89989-01-5(Hazardous Substances Data)

Usage

General Description

1-(4-chloro-2-Methoxyphenyl)piperazine is a chemical compound with the molecular formula C11H14ClN2O. It is a piperazine derivative with a chloro and methoxy group attached to the phenyl ring. 1-(4-chloro-2-Methoxyphenyl)piperazine is mainly used as a research chemical and has been studied for its potential pharmaceutical applications, such as its use in the treatment of central nervous system disorders and other medical conditions. It is also known to have some psychoactive effects, and therefore, it is important to handle and use this compound with caution to prevent any potential harm or misuse. Overall, 1-(4-chloro-2-Methoxyphenyl)piperazine is a compound with potential medicinal and research applications, but its effects and usage should be carefully evaluated and monitored.

Upstream product

• 93-50-5 4-chloro-o-anisidine 
• 821-48-7 bis-(2-chloroethyl)amine hydrochloride 

Relevant articles and documents

Heteroaromatic acetamide derivative, preparation and applications thereof

The present invention provides a heteroaromatic acetamide derivative, a preparation and applications thereof, wherein the derivative comprises a pharmaceutically acceptable salt and/or a solvate thereof. According to the present invention, the experiment results prove that the heteroaromatic acetamide derivative can specifically bind to transient receptor potential ankyrin 1 (TRPA1) and inhibit orreduce the activity of TRPA1, and can be used for treating diseases mediated by TRPA1; and the inhibitor of the present invention further comprises a pharmaceutical composition of the compound, and amethods for preparing the compounds. The derivative has a general formula defined in the specification.

PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS

Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, X, and n are as defined for Formula (I) in the description, processes for the preparation of the compounds and new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and the use of the compounds in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction.